Medication info
Empagliflozin 10 mg Tablet

Empagliflozin 10 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Pale yellow, round film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTP×3)]
Approval status
Active

MFDS item code 202105849 · Approved 2021.08.11 · Insurance code 643508890

Summary

Main use
Improves type 2 diabetes, prevents hospitalization for chronic heart failure, and slows the progression of chronic kidney disease
Who takes it
Adults
Adult dose
Type 2 diabetes mellitus The recommended dose of this medicine is 10 mg once daily, as monotherapy or as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. Chronic heart failure The recommended dose of this medicine is 10 mg once daily. Chronic kidney disease The recommended dose of this medicine is 10 mg once daily. This medicine should be administered in combination with other standard therapies for chronic kidney disease. Type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations Patients with renal impairment Type 2 diabetes mellitus This medicine is not recommended for improving glycemic control in patients with an estimated glomerular filtration rate (eGFR) < 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate ≥ 45 ml/min/1.73m2. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. Chronic heart failure This medicine should not be used in patients with an estimated glomerular filtration rate (eGFR) < 20 ml/min/1.73m2. Chronic kidney disease This medicine may be used regardless of renal function. However, because experience is limited, initiation of this medicine is not recommended in patients with an estimated glomerular filtration rate (eGFR) < 20 ml/min/1.73m2. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older (see Precautions for Use, 4. General Precautions).

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Improves type 2 diabetes, prevents hospitalization for chronic heart failure, and slows the progression of chronic kidney disease

  • Type 2 diabetes
  • chronic heart failure
  • chronic kidney disease
View approved original text

This medication is primarily used in conjunction with dietary and exercise regimens to help control blood sugar in adults with type 2 diabetes. It also helps reduce the risk of death and hospitalization due to cardiovascular disease in patients with chronic heart failure. Additionally, it is effective in reducing the risk of deterioration of kidney function or death due to cardiovascular disease in patients with chronic kidney disease. Therefore, this medication plays an important role not only in diabetes management but also in managing heart failure and kidney disease, thereby improving health status.

How to take

Adult dose

Type 2 diabetes mellitus The recommended dose of this medicine is 10 mg once daily, as monotherapy or as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. Chronic heart failure The recommended dose of this medicine is 10 mg once daily. Chronic kidney disease The recommended dose of this medicine is 10 mg once daily. This medicine should be administered in combination with other standard therapies for chronic kidney disease. Type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations Patients with renal impairment Type 2 diabetes mellitus This medicine is not recommended for improving glycemic control in patients with an estimated glomerular filtration rate (eGFR) < 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate ≥ 45 ml/min/1.73m2. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. Chronic heart failure This medicine should not be used in patients with an estimated glomerular filtration rate (eGFR) < 20 ml/min/1.73m2. Chronic kidney disease This medicine may be used regardless of renal function. However, because experience is limited, initiation of this medicine is not recommended in patients with an estimated glomerular filtration rate (eGFR) < 20 ml/min/1.73m2. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older (see Precautions for Use, 4. General Precautions).

Precautions

This medication should not be used by those who are allergic to the active ingredient or any of the components. It should not be administered to type 1 diabetes patients or those with diabetic ketoacidosis, and patients who genetically cannot digest lactose should not take this medication. For patients with poor kidney function, kidney function should be regularly monitored while using this medication, and it is not recommended for patients with severely low kidney function. There is a risk of hypoglycemia when taken with insulin or insulin-secreting medications, so dose adjustment may be necessary. Patients should be carefully monitored for side effects such as hypoglycemia, infections, especially genital and urinary tract infections, decreased fluid volume, and increased urination while taking this medication. Rarely, severe metabolic abnormalities known as ketoacidosis may occur, and if symptoms appear, immediate consultation with medical professionals is necessary. Elderly patients or those at risk of fluid volume loss should be cautious of dehydration or hypotension, and monitoring of fluid status is recommended. This medication has been reported to cause liver damage, so liver health should also be carefully monitored. Caution is required during driving or operating machinery due to the risk of hypoglycemia, especially when used in conjunction with insulin and similar products. Women who are pregnant or breastfeeding should avoid taking this medication, and it should be immediately discontinued upon confirmation of pregnancy. Children should not use this medication as safety and efficacy have not been established. No specific toxic symptoms have been reported in cases of overdose, but appropriate treatment is needed based on clinical status. This medication should be kept out of the reach of children, and transferring it to another container should be avoided to maintain quality and safety.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • constipation
  • pruritus
  • rash
  • urticaria
  • angioedema
  • decreased fluid volume
  • increased urination
  • urinary difficulty
Show 200 more
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • vulvar vaginitis
  • balanitis
  • other genital infections
  • urinary tract infection
  • perineal necrosis
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • intestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral calculi
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • low back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • macular detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • otalgia
  • positional vertigo
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • upper abdominal pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • enteritis
  • flatulence
  • gastric polyp
  • gingival swelling
  • passage of bloody stools
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • dry mouth
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • tinea corporis
  • dental abscess
  • nasopharyngitis
  • positional dizziness
  • sensory loss
  • perceptual disturbances
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory disturbances
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • CNS-origin vertigo
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • pain at the site of puncture
  • weight gain
  • abnormal ECG
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • hyperactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • urinary abnormalities
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • scrotal pain
  • sexual dysfunction
  • decreased appetite
  • obesity
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • circular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • eye congestion
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • cough
  • skin laceration
  • bruise
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • anxiety
  • depression
  • sleep disorder
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture ingress and should be kept at a temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness for a longer period.

Appearance and packaging

Appearance

Pale yellow, round film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP×3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.